Used in pharmaceutical research as a key intermediate in the synthesis of targeted protein degraders, particularly cereblon E3 ligase modulators. Its structure enables conjugation to other pharmacophores for developing PROTACs (proteolysis-targeting chimeras), which are investigational drugs designed to degrade disease-causing proteins. The iodopropyl group facilitates further chemical modifications through coupling reactions, making it valuable in creating compound libraries for drug discovery. Also employed in biochemical assays to study protein-protein interactions and ubiquitination pathways.